Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

ConditionsCardiac Sarcoidosis Sarcoidosis of the Heart Sarcoidosis With Myocarditis Sarcoidosis, Cardiac

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorMayo Clinic

About this trial

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Eligibility criteria

Qualifiers

Adults ≥18 years.

Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.

Undergoing FDG-PET as part of standard care.

Ability to provide informed consent.

Disqualifiers

None

Trial design

Treatments tested in this trial

Exosome Analysis

Treatment groups

115 Participants

are divided into 1 treatment group

Locations

Mayo Clinic in Rochester55905, RochesterMinnesota, United States

Sponsors and collaborators

Mayo Clinic

Lead sponsor

Source ClinicalTrials.gov